Komo Biosciences
PrivateLast Round
Seed
Jul 9, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Komo Biosciences is a biotechnology company that provides a next-generation precision genome engineering technology for the development and manufacturing of therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Komo Biosciences Comparables
Compare Komo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IntegraTherapeutics | 80% | |
| Stylus Medicine | 77% | |
| Prime Medicine | 76% |
Komo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 9, 2024 |
Key People
Founding team and executive leadership
Komo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genesis BioCapital | Seed |
| Eshelman Ventures | Seed |
| LDV Partners | Seed |
| Modi Ventures | Seed |
| General Inception | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 279% MoM, reaching 1.9K.
- Jul 26, 2026
Monthly visitors grew 157% MoM, reaching 493.
Komo Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Komo Biosciences's valuation, stock price, and market status.
Is Komo Biosciences a public or private company?
Komo Biosciences is a private company.
What is the current stock price of Komo Biosciences?
Komo Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Komo Biosciences worth (valuation)?
Valuation information for Komo Biosciences is not publicly available.
Can I buy Komo Biosciences stock?
Komo Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Komo Biosciences's last funding round?
Komo Biosciences's most recent funding round was Seed on July 9, 2024.
Who are the main investors in Komo Biosciences?
Key investors in Komo Biosciences include Genesis BioCapital.
Will Komo Biosciences IPO soon?
No public IPO plans have been announced for Komo Biosciences.
How can I track Komo Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Komo Biosciences's secondary market activity and sign up for updates.